WTF Are You Waiting ForJust another Site 1 Sites site

A thesis from the University of Gothenburg (Sweden) is the first in Scandinavia to study the occurrence of low bone mineral density in children and teenagers with inflammatory bowel disease. Half of the patients in the study showed signs of low bone mineral density…

Original post: Low Bone Mineral Density Common In Children And Teenagers With Inflammatory Bowel Disease

A complex sugar may someday become one of the most effective weapons to stop the spread of cholera, a disease that has claimed thousands of lives in Haiti since the devastating earthquake last year. A technique developed by University of Central Florida scientists would allow relief workers to test water sources that could be contaminated with the cholera toxin…

Original post: Special Sugar, Nanoparticles Combine To Detect Cholera Toxin

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Forest Laboratories, Inc. (NYSE: FRX) today announced positive top-line results from the firs of two Phase 3 clinical trials assessing the efficacy and safety of the investigational drug, linaclotide, in patients with irritable bowel syndrome with constipation (IBS-C)…

Original post: Ironwood And Forest Announce Positive Linaclotide Results From Phase 3 Trial In Patients With Irritable Bowel Syndrome With Constipation

Antioxidant supplements may benefit couples who have difficulty conceiving naturally, according to a new systematic review published today in The Cochrane Library. The review provides evidence from a small number of trials that suggest the partners of men who take antioxidants are more likely to become pregnant. Male subfertility affects one in 20 men…

Original post: Antioxidants May Improve Chances Of Conceiving In Male Subfertility

AMRI (NASDAQ: AMRI) announced the selection of a compound from its proprietary research program for the treatment of irritable bowel syndrome (IBS) for advanced preclinical testing, with the goal of submitting an Investigational New Drug Application (IND) with the U.S. Food and Drug Administration (FDA) in 2011…

Original post: AMRI Advances New Irritable Bowel Syndrome Treatment Toward IND Submission

The American Academy of Dermatology (Academy) has updated its position statement on vitamin D based on the results of a review of the increasing body of scientific literature on this vitamin and its importance for optimal health recently conducted by the National Academy of Sciences Institute of Medicine (IOM)…

Original post: American Academy Of Dermatology Issues Updated Position Statement On Vitamin D

People living with ulcerative colitis (UC) say greater understanding is needed about the life-altering nature of this chronic inflammatory bowel disease that affects approximately 500,000 Americans…

Original post: Voices Of UC Survey Shows Need For Patients With Ulcerative Colitis To Speak Up About Debilitating Digestive Disease

The tech industry applauds as music goes digital. But in towns like Pitman, N.J., innovation comes at a price.

Original post: What happens when the CD factory closes?

Mederi Therapeutics Inc announced that it has received a CE Mark authorizing the European distribution and use of Mederi’s second generation of the Stretta and Secca Systems. The Stretta System is for treatment of gastric reflux disease, commonly known as GERD, and the Secca System is for treatment of bowel control disorder, or BCD…

Original post: Mederi Therapeutics Announces Receipt Of CE Mark For Its Second Generation Secca® And Stretta® Systems

The European music service cut its first licensing deal for a U.S. launch with one of the four top labels–Sony. Can signing Universal help speed up a launch?

Original post: Key for Spotify in the U.S. is Universal Music